Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.
about
Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.Proteomics of Mycobacterium Infection: Moving towards a Better Understanding of Pathogen-Driven Immunomodulation.Human Monocytic Suppressive Cells Promote Replication of and Alter Stability of Generated Granulomas
P2860
P800
Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Suppressor Cell-Depleting Immu ...... cted Therapy for Tuberculosis.
@en
type
label
Suppressor Cell-Depleting Immu ...... cted Therapy for Tuberculosis.
@en
prefLabel
Suppressor Cell-Depleting Immu ...... cted Therapy for Tuberculosis.
@en
P2093
P2860
P356
P1476
Suppressor Cell-Depleting Immu ...... cted Therapy for Tuberculosis.
@en
P2093
Haidan Guo
John R Murphy
Laurene Cheung
Shashank Gupta
Supriya Pokkali
William R Bishai
P2860
P304
P356
10.1093/INFDIS/JIX208
P407
P577
2017-06-01T00:00:00Z